Table 2.
Clinico-pathological data of patients who underwent pancreas duct occlusion included in follow-up program.
| Duct occlusion, n = 48 | Fistula, n = 31 | No fistula, n = 17 | P -value | |
|---|---|---|---|---|
| Histological findings, n (%) | ||||
| Pancreatic adenocarcinoma Ampullary adenocarcinoma Bile duct cancer Neuroendocrin carcinoma Mucinous cystadenoma Gallbladder cancer Choronic pancreatitis |
24 (50) 10 (20.84) 6 (12.50) 3 (6.25) 3 (6.25) 1 (2.08) 1 (2.08) |
14 (45.16) 6 (19.35) 5 (16.14) 2 (6.45) 3 (9.68) 1 (3.22) - |
10 (58.83) 4 (23.53) 1 (5.88) 1 (5.88) - - 1 (5.88) |
0.5469 0.7266 0.4022 1.0000 0.5430 1.0000 0.3542 |
| Pancreatic texture, n (%) | ||||
| Soft Hard Normal |
33 (68.75) 8 (16.67) 7 (14.58) |
25 (80.65) 5 (16.13) 1 (3.22) |
8 (47.06) 3 (16.65) 6 (35.39) |
0.0164 1.0000 0.0055 |
| Pancreatic duct diameter | ||||
| Mean, mm Range, mm ≤ 3 mm, n (%) > 3mm, n (%) |
3.98 (± 2.18) 1–10 19 (39.58) 29 (60.42) |
4.25 (± 1.88) 3–10 |
5.00 (± 2.14) 1–8 |
0.2145 |
| Hematic amylase, UI/l | ||||
| Pre-operative mean (± SD) Post-operative, mean (± SD) 7 days p.o., mean (± SD) |
178.41 (± 201.37) 451.31 (± 510.78) 74.10 (± 57.44) |
202.75 (±236.89) 557.37 (±567.52) 88.10 (±60.90) |
139.47 (±123.41) 246.33 (±298.06) 47.93 (±40.21) |
0.3110 0.0413 0.0187 |